Stockreport

French biotech company Valneva raises product sales guidance [Reuters]

Valneva SE - American Depositary Shares  (VALN) 
PDF it now expects revenues of between 170 million euros and 190 million euros ($184.72 million to $206.45 million) in 2024, as it anticipates sales growth of its travel vac [Read more]